1. Home
  2. PLX vs BDSX Comparison

PLX vs BDSX Comparison

Compare PLX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.98

Market Cap

159.5M

Sector

Health Care

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$13.95

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLX
BDSX
Founded
1993
2005
Country
United States
United States
Employees
226
334
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.5M
143.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
PLX
BDSX
Price
$1.98
$13.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$32.50
AVG Volume (30 Days)
767.9K
75.6K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$52,744,000.00
$88,499,000.00
Revenue This Year
$36.81
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$9.07
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.34
$0.25
52 Week High
$3.19
$20.21

Technical Indicators

Market Signals
Indicator
PLX
BDSX
Relative Strength Index (RSI) 36.37 54.97
Support Level $1.87 $12.77
Resistance Level $2.15 $16.26
Average True Range (ATR) 0.11 1.19
MACD 0.00 0.26
Stochastic Oscillator 31.40 71.92

Price Performance

Historical Comparison
PLX
BDSX

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: